HAE Institutional Ownership
HAEMONETICS CORP
Latest close $87.84 as of Aug 7, 2026
HAE institutional ownership at a glance
Follow HAEMONETICS CORP institutional ownership through recent Schedule 13G and 13D filings. Compare reported shares, ownership percentages, filing dates, and changes in beneficial ownership over time.
Latest filing: T. Rowe Price Investment Management filed Schedule 13G amendment on May 14, 2025, reporting 2.2M shares and 12.00% beneficial ownership.
How to read Schedule 13 ownership changes
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
Institutional Research
This gauge summarizes recent agreement across tracked institutional activity.
1 accumulating, 1 reducing across 2 comparable institutions.
The overall consensus is public. Detailed holder comparisons, breadth history, ownership charts, and filing-specific signal analysis remain part of Investor and Pro research.
Price context
52-week position is market context and does not change the institutional consensus score.
Tracked institutions
Public holder names and filing freshness. Detailed institution-by-institution analysis is locked.
Beneficial ownership filing history
Showing 3 of 9 filing(s) · 6 older require more history access| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| T. Rowe Price Investment Management CIK0001897612 | Mar 31, 2025 observed May 14, 2025 filed · 44d Schedule 13G amendment | Reported reduction | 2.2M -655.1K | 12.00% +6.40 pts | $63.55 | $68.65 | $87.84 |
| Capital Research Global Investors CIK0001422848 | Mar 31, 2025 observed Apr 4, 2025 filed · 4d Schedule 13G amendment | Reported accumulation | 50.2M +45.8M | 12.00% +3.30 pts | $63.55 | $60.88 | $87.84 |
| T. Rowe Price Investment Management CIK0001897612 | Sep 30, 2024 observed Nov 14, 2024 filed · 45d Initial Schedule 13G | Initial Schedule 13G | 2.9M | 5.60% | $80.38 | $90.75 | $87.84 |
Related research
Compare HAE with other securities showing similar institutional activity or recent accumulation across several tracked institutions.